⌘K (Command K) to search

Sign in Sign up free

Insider · CIK 0001727807

Elliott Russell P.

Reports to the SEC for 1 company · REHOVOT, L3

Transactions

9

Companies

1

Filings

6

CIK

0001727807

Forms 4 and 5

Insider transactions

9 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2018-10-01	Foamix Pharmaceuticals Ltd.S Sale	VP Drug Development	SSale	−142 sh	$5.81	−$825.02	12,442
2018-07-02	Foamix Pharmaceuticals Ltd.S Sale	VP Drug Development	SSale	−142 sh	$5.10	−$724.2	12,584
2018-04-02	Foamix Pharmaceuticals Ltd.S Sale	VP Drug Development	SSale	−142 sh	$5.08	−$721.36	12,726
2018-03-02	Foamix Pharmaceuticals Ltd.S Sale	VP Drug Development	SSale	−817 sh	$6.14	−$5,016.38	12,868
2018-02-27	Foamix Pharmaceuticals Ltd.OptionsA Award	VP Drug Development	AAward	+26.3K sh	$6.35	+$167K	26,250
2018-02-27	Foamix Pharmaceuticals Ltd.A Award	VP Drug Development	AAward	+8,750 sh	—	—	13,685
2018-01-02	Foamix Pharmaceuticals Ltd.F Tax Payment	VP Drug Development	FTax Payment	−555 sh	$5.98	−$3,318.9	4,935
2018-01-01	Foamix Pharmaceuticals Ltd.M Exercise/Conversion	VP Drug Development	MExercise/Conversion	+1,372 sh	—	—	5,490
2018-01-01	Foamix Pharmaceuticals Ltd.Restricted Share UnitsM Exercise/Conversion	VP Drug Development	MExercise/Conversion	−1,372 sh	—	—	0

Recent filings

6

Accepted (ET)
Oct 24
Elliott Russell P.0001178913-18-002611
SEC(opens sec.gov)
Jul 34
Elliott Russell P.0001178913-18-002030
SEC(opens sec.gov)
Apr 44
Elliott Russell P.0001178913-18-001112
SEC(opens sec.gov)
Mar 64
Elliott Russell P.0001178913-18-000771
SEC(opens sec.gov)
Feb 284
Elliott Russell P.0001178913-18-000718
SEC(opens sec.gov)
Jan 244
Elliott Russell P.0001178913-18-000265
SEC(opens sec.gov)

Companies

1

Foamix Pharmaceuticals Ltd.VP Drug Development

Address

C/O FOAMIX PHARMACEUTICALS LTD. 2 HOLZMAN STREET, WEIZMANN SCIENCE PARK

REHOVOT, L3, 7670402